HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 181-192 of 4,505
Drug study icon
RecruitingNCT07114874

Long-term safety of NBI-1117568 in schizophrenia

About this title

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Read the official source — NCT07114874
What is this study about?

Researchers are studying NBI-1117568, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.

Multiple locations, including Bryant
SchizophreniaMedication studyAges 18–65
Countries
United States, Bulgaria, Romania, + 1 other
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT06340789

Sodium benzoate or placebo added when schizophrenia treatment has not helped enough

About this title

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Read the official source — NCT06340789
Official study title

Functional Connectivity and Associated Neuropeptides Variations in Treatment Resistant Schizophrenia Patients: Treatment Efficacy of add-on Sodium Benzoate

In Chiayi City
SchizophreniaMedication studyAges 20–55
Countries
Taiwan
Sponsor
National Cheng-Kung University Hospital
Drug study icon
RecruitingNCT06961968

Iloperidone injection to prevent schizophrenia relapse

About this title

Randomized Withdrawal Study in Patients With Schizophrenia

Read the official source — NCT06961968
Official study title

A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection

Multiple locations, including Rogers
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Vanda Pharmaceuticals
Behavioral study icon
RecruitingNCT05299749

fMRI brain feedback for voices that persist despite treatment in schizophrenia

About this title

Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations

Read the official source — NCT05299749
Official study title

Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients With Schizophrenia - R33 Phase

In Brockton
SchizophreniaInterventional studyAges 18–55
Countries
United States
Sponsor
Boston VA Research Institute, Inc.
Device study icon
RecruitingNCT05956951

Sound stimulation during sleep in schizophrenia

What is this study about?

Researchers are comparing sleep-related brain activity in early-course schizophrenia and healthy volunteers, and testing whether sounds during deep sleep affect sleep features and cognitive performance.

In Pittsburgh
SchizophreniaSleep stimulation deviceAges 18–40
Countries
United States
Sponsor
Fabio Ferrarelli

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.